FrancophonIA/ELRC3.0 huggingface dataset:
English: Not all of these pens may be marketed in your country (see section 4.2 and 6.6)
Maltese: Jista' jkun li dawn il-pinen mhux kollha jkunu fis-suq fil-pajjiż tiegħek (ara sezzjonijiet 4.2 u 6.6).
English: Concentrations were thus consistent with the time profile of the pharmacodynamic activity of insulin glargine.
Maltese: Il-konċentrazzjonijiet, għalhekk, kienu konsisteni mal-profil talħin ta' l-attività farmakodinamika ta' insulin glargine.
English: 5 cartridges of 3 ml.
Maltese: 5 skartoċċi ta' 3 ml.
English: In clinical studies, antibodies that cross-react with human insulin and insulin glargine were observed with the same frequency in both NPH-insulin and insulin glargine treatment groups.
Maltese: F'studji kliniċi, l-antikorpi li jirreaġixxu kemm mal-insulina umana u kemm mal-insulina glargine ġew osservati bl-istess frekwenza fiż-żewġ gruppi ta' kura ta' NPH-insulin u insulina glargine.
English: In many patients, the signs and symptoms of neuroglycopenia are preceded by signs of adrenergic counter-regulation.
Maltese: F'ħafna pazjenti, is-sinjali u s-sintomi ta' neurogylcopenia iseħħu wara sinjali ta' kontro-regolazzjoni adreneġika.
English: Alternative site 10 ml vials:
Maltese: Kunjett ta' 10 ml:
English: Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Germany.
Maltese: Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, il-Ġermanja.
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE
Maltese: MANIFATTUR TAS-SUSTANZA BIJOLOĠIKA ATTIVA U DETENTURI TA' L-AWTORIZZAZZJONI TAL-MANIFATTURA RESPONSABBLI
English: Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main, Germany.
Maltese: Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main, il-Ġermanja.
English: Store in a refrigerator (2°C-8°C).
Maltese: Aħżen fil-friġġ (2°Ċ-8°Ċ).
English: It is completely soluble at the acidic pH of the Lantus injection solution (pH 4).
Maltese: Hi tinħall għal kollox fil-pH aċiduża tas-soluzzjoni għall-injezzjoni ta' Lantus (pH 4).
English: Insulin inhibits lipolysis in the adipocyte, inhibits proteolysis and enhances protein synthesis.
Maltese: L-insulina tinibixxi l-lipoliżi fit-tessut xaħmi u l-protejoliżi u tinkuraġġixxi s-sinteżi tal-proteini.
English: Although Lantus contains the same active substance as Toujeo (insulin glargine 300 units/ml), these medicines are not interchangeable.
Maltese: Għalkemm Lantus fih l-istess sustanza attiva bħal Toujeo (insulin glargine 300 unità/ml), dawn il-mediċini ma jistgħux jinbidlu ma' xulxin.
English: Examples of symptoms that indicate a low sugar level in the brain: headaches, intense hunger, nausea, vomiting, tiredness, sleepiness, sleep disturbances, restlessness, aggressive behaviour, lapses in concentration, impaired reactions, depression, confusion, speech disturbances (sometimes total loss of speech), visual disorders, trembling, paralysis, tingling sensations (paraesthesia), numbness and tingling sensations in the area of the mouth, dizziness, loss of self-control, inability to look after yourself, convulsions, loss of consciousness.
Maltese: Ezempji ta' sintomi li jindikaw livell baxx taz-zokkor fil-moħħ: uġigħ ta' ras, ġuħ kbir, dardir, remettar, għeja, ngħas, disturbi fl-irqad, nuqqas ta' kwiet, komportament aggressiv, nuqqas ta' attenzjoni, reazzjonijiet imfixklin, depressjoni, konfużjoni mentali, taħwid fid-diskors, (xi drabi it-telf komplet tad-diskors), indeboliment tal-vista, rogħda, paralisi, tnemnim (parasteżija), sensazzjoni mtarrxa u tnemnim fir-reġjun talħalq, sturdament, inabbiltà li trażżan lilek innifsek, inabbiltà li tieħu ħsieb tiegħek innifsek, aċċessjonijiet u t telf mis-sensi.
English: The Lantus cartridges should only be used with the following pens: - JuniorSTAR which delivers Lantus in 0.5 unit dose increments - ClikSTAR, Tactipen, Autopen 24, AllStar and AllStar PRO which all deliver Lantus in 1 unit dose increments.
Maltese: - JuniorSTAR li tagħti Lantus f'żidiet fid-doża ta' 0.5 unitajiet - ClikSTAR, Tactipen, Autopen 24, AllStar u AllStar PRO li kollha jagħtu Lantus f'żidiet fid-doża ta' unità
English: Excipients: zinc chloride, metacresol, glycerol, hydrochloric acid and sodium hydroxide (for pH adjustment), polysorbate 20, , water for injections.
Maltese: Eċċipjenti: zinc chloride, metacresol, glycerol, hydrochloric acid u sodium hydroxide (għall-aġġustament talpH), polysorbate 20, ilma għall-injezzjonijiet
English: Sanofi Romania SRL Tel: +40 (0) 21 317 31 36
Maltese: Tel: +40 (0) 21 317 31 36
English: 10 cartridges of 3 ml.
Maltese: 10 skartoċċi ta' 3 ml.
English: Each vial contains 5 ml of solution for injection (equivalent to 500 units) or 10 ml of solution for injection (equivalent to 1000 units).
Maltese: Kull kunjett fih 5 ml ta' soluzzjoni għall-injezzjoni (ekwivalenti għal 500 unità) jew 10 ml ta' soluzzjoni għall-injezzjoni (ekwivalenti għal 1000 unità).
English: 9 cartridges of 3 ml.
Maltese: 9 skartoċċi ta' 3 ml.
English: OUTER CARTON (cartridge)
Maltese: Ż-ŻGĦAR EWLENIN TIKKETTA (skartoċċ)
English: Lantus 100 units/ml solution for injection insulin glargine
Maltese: Lantus 100 unità /ml soluzzjoni għall-injezzjoni insulin glargine
English: A 24-week parallel group study was conducted in 125 children with type 1 diabetes mellitus aged 2 to 6 years, comparing insulin glargine given once daily in the morning to NPH insulin given once or twice daily as basal insulin.
Maltese: Fi studju parallel li dam sejjer 24 ġimgħa fuq 125 tifel u tifla b'dijabete mellitus tat-tip 1 u li kellhom minn sentejn sa 6 snin, fejn ġiet imqabbla l-insulina glargine mogħtija darba kuljum filgħodu ma insulina NPH mogħtija darba jew darbtejn kuljum bħala insulina bażika.
English: Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
Maltese: Kura għal diabetes mellitus fl-adulti, l-adoloxxenti u t-tfal minn sentejn 'il fuq.
English: Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH.
Maltese: Insulin glargine hija insulina analoga umana imfassla b`mod li ma tinħallx biżżejjed f'pH newtrali.
English: Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia include oral antidiabetic medicinal products, angiotensin converting enzyme (ACE) inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, pentoxifylline, propoxyphene, salicylates and sulfonamide antibiotics.
Maltese: Sustanzi li jistgħu jżidu l-effett tat-tnaqqis fil-livell tal-glukożju fid-demm, u jżidu r-riskju għall-iżvilupp ta' l-ipogliċemija, jinkludu prodotti mediċinali orali kontra d-dijabete, inibituri ta' l-enzima li tikkonverti angiotensin (ACE), disopyramide, fibrati, fluoxetine, inibituri ta' monamine oxidase (MAO), pentoxifylline, propoxyphene, salicylates, u l-antibijotiċi sulphonamide.
English: Insulin mix-ups
Maltese: Tiddilwiehx.
English: 4 cartridges of 3 ml.
Maltese: 4 skartoċċi ta' 3 ml.
English: Dose
Maltese: Tqala
English: Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen Type 1 colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with a stopper (bromobutyl or laminate of polyisoprene and bromobutyl rubber) containing 3 ml of solution.
Maltese: Lantus SoloStar 100 unità/ml soluzzjoni għall-injezzjoni f'pinna mimlija għal-lest Skartoċċ tal-ħġieġ tip 1 mingħajr kulur bi planġer iswed (lastku bromobutyl) u għatu bi flanġ (aluminju), b'tapp (lastku bromobutyl jew b'safef ta' lastku polyisoprene u bromobutyl) li fih 3 ml ta' soluzzjoni.
English: A crossover study comparing insulin glargine plus lispro insulin to NPH plus regular human insulin (each treatment administered for 16 weeks in random order) in 26 adolescent type 1 diabetic patients aged 12 to 18 years was also performed.
Maltese: Sar ukoll studju fejn il-pazjenti jingħataw il-kura b'mod arbitrarju(crossover study), fejn ġew imqabbla insulin glargine flimkien ma' lispro insulin u NPH flimkien ma' insulina umana regolari (kull kura ngħatat għal 16-il-ġimgħa b'mod arbitrarju) f'26 pazjent adolexxenti dijabetiċi tat-tip I b'etajiet minn 12 sa 18-il sena.
English: Packs of 1, 3, 4, 5, 6, 8, 9 and 10 cartridges.
Maltese: Pakketti ta' 1, 3, 4, 5, 6, 8, 9 u 10 skartoċċi
English: Excipients: zinc chloride, metacresol, glycerol, hydrochloric acid and sodium hydroxide (for pH adjustment) and water for injections.
Maltese: Eċċipjenti: zinc chloride, metacresol, glycerol, hydrochloric acid u sodium hydroxide (għall-aġġustament tal pH) u ilma għall-injezzjonijiet.
English: Lantus 100 units/ml solution for injection in a cartridge Type 1 colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with a stopper (bromobutyl or laminate of polyisoprene and bromobutyl rubber) containing 3 ml of solution.
Maltese: Lantus 100 unità/ml soluzzjoni għall-injezzjoni fi skartoċċ Skartoċċ tal-ħġieġ tip 1 mingħajr kulur bi planġer iswed (lastku bromobutyl) u għatu bi flanġ (aluminju), b'tapp (lastku bromobutyl jew b'safef ta' lastku polyisoprene u bromobutyl) li fih 3 ml ta' soluzzjoni.
English: Combination of Lantus with pioglitazone
Maltese: taħt il-ġilda
English: Packs of 1, 3, 4, 5, 6, 8, 9 and 10 SoloStar pre-filled pens.
Maltese: Pakketti ta' 1, 3, 4, 5, 6, 8, 9 u 10 pinen mimlijin għal-lest SoloStar.
English: 6 cartridges of 3 ml.
Maltese: 6 skartoċċi ta' 3 ml.
English: Lantus 100 units/ml solution for injection in a vial Lantus 100 units/ml solution for injection in a cartridge Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen
Maltese: Lantus 100 unità/ml soluzzjoni għall-injezzjoni fi skartoċċ, Lantus SoloStar 100 unità/ml soluzzjoni għall injezzjoni f'pinna mimlija għal-lest
English: Empty cartridges must not be refilled.
Maltese: Għandha tkun immaniġġata bir-reqqa.
English: In a clinical study, symptoms of hypoglycaemia or counter-regulatory hormone responses were similar after intravenous insulin glargine and human insulin both in healthy volunteers and patients with type 1 diabetes.
Maltese: Fi studju kliniku, is-sintomi ta' l-ipogliċemija jew ir-rispons ormonali kontro-regolatorju kienu simili wara insulin glargine intravenuż u insulina umana intravenuża, kemm f'individwi voluntiera b'saħħithom kif ukoll f'pazjenti bid-dijabete tip 1.
English: Excipients: zinc chloride, metacresol, glycerol, hydrochloric acid and sodium hydroxide (for pH adjustment) and water for injections
Maltese: Eċċipjenti: zinc chloride, metacresol, glycerol, hydrochloric acid u sodium hydroxide (għall-aġġustament talpH), u ilma għall-injezzjonijiet
English: - in whom an autonomic neuropathy is present, - with a long history of diabetes, - suffering from a psychiatric illness, - receiving concurrent treatment with certain other medicinal products (see section 4.5).
Maltese: - li jsofru bmard psikjatriku, - li qed jieħdu t-trattament flimkien ma' ċerti prodotti mediċinali oħra (ara sezzjoni 4.5).
English: Rare reported side effect (may affect up to 1 in 1,000 people)
Maltese: Effett sekondarju rrapportat b'mod rari (jistgħu jaffettwaw sa persuna 1 minn kull 1,000)
English: Pack sizes of 1, 3, 4, 5, 6, 8, 9 and 10 cartridges.
Maltese: Daqsijiet tal-pakkett ta' 1, 3, 4, 5, 6, 8, 9 u 10 skartoċċi.
English: 3 cartridges of 3 ml.
Maltese: 3 skartoċċi ta' 3 ml.
English: HbA1c changes from baseline were similar between treatment groups; however blood glucose values recorded overnight were significantly higher in the insulin glargine/ lispro group than the NPH/regular group, with a mean nadir of 5.4 mM versus 4.1 mM.
Maltese: Tibdiliet fl-HbA1c mil-linja bażi kienu simili għaż-żewġ gruppi ta' kura; madankollu l-valuri tal-glukożju fid-demm meħud mal-lejl kienu ogħla b'mod sinifikanti fil-grupp tal-insulin glargine/lispro milli fil-grupp NPH/regolari bl-inqas livell jilħaq medja ta' 5.4 mM kontra. 4.1 mM.
English: Lantus SoloStar 100 units/ml solution for injection insulin glargine
Maltese: Lantus SoloStar 100 unità/ml soluzzjoni għall-injezzjoni.
English: Marketing Authorisation Holder and Manufacturer
Maltese: MANIFATTUR TAS-SUSTANZA BIJOLOĠIKA ATTIVA U MANIFATTURI
English: Packs of 1, 2, 5 and 10 vials
Maltese: Pakketti ta' 1, 2, 5 u 10 kunjetti. kunjett ta' 10 ml
English: At the last on-treatment visit, there was a mean increase in body weight from baseline of 1.4 kg in the insulin glargine group and a mean decrease of 0.8 kg in the standard care group.
Maltese: Waqt l-aħħar viżta ta' matul il-kura, kien hemm medja ta' żieda fil-piż tal-ġisem mil-linja bażi ta' 1.4 kg filgrupp ta' insulin glargine u medja ta' tnaqqis ta' 0.8 kg fil-grupp ta' kura standard.
English: B. Take off the pen cap.
Maltese: Neħħi l-kappa mill-pinna.
English: Lantus contains insulin glargine, an insulin analogue, and has a prolonged duration of action.
Maltese: Lantus fih insulin glargine, analogu ta' l-insulina li jaħdem għal perijodu twil ta' żmien.
English: In general, the safety profile for children and adolescents (≤18 years of age) is similar to the safety profile for adults.
Maltese: Ġeneralment, il-profil ta' sigurtà fit-tfal u fl-adolexxenti (≤ 18-il sena) huwa l-istess bħall-profil ta' sigurtà għall-adulti.
English: Immediately take about 10 to 20 g sugar, such as glucose, sugar cubes or a sugar-sweetened beverage.
Maltese: Immedjatament ħu madwar 10 sa 20 g zokkor, bħal glukosju, dadi taz-zokkor, jew xi xarba ħelwa li fiha z-zokkor.
English: Type 1 colourless glass vial with a flanged cap (aluminium), a stopper (type 1, laminate of polyisoprene and bromobutyl rubber) and a tear-off cap (polypropylene) containing 10 ml of solution.
Maltese: Kunjett tal-ħġieġ tip 1 mingħajr kulur b'għatu bi flanġ (aluminju), tapp (tip 1, b'safef ta' lastku polyisoprene u bromobutyl) u għatu li jiċċarrat (polypropylene) li fih 10 ml ta' soluzzjoni.
English: 6.3 Shelf-life
Maltese: Siġill Protettiv
English: OUTER CARTON (10 ml vial)
Maltese: Ż-ŻGĦAR EWLENIN TIKKETTA (kunjett ta' 10ml)
English: OUTER CARTON (5 ml vial)
Maltese: Ż-ŻGĦAR EWLENIN TIKKETTA (kunjett ta' 5ml)
English: PEN LABEL (Pre-filled pen.SoloStar)
Maltese: Labra tal-Pinna (mhux inkluża)
English: In use conditions:
Maltese: Kunjetti mhux miftuħin:
English: Effects of insulin glargine (once daily) on diabetic retinopathy were evaluated in an open-label 5 year NPH-controlled study (NPH given bid) in 1024 type 2 diabetic patients in which progression of retinopathy by 3 or more steps on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale was investigated by fundus photography.
Maltese: L-effetti ta' insulin glargine (darba kuljum) fuq retinopatija tad-dijabete ġew evalwati f'1024 pażjent fi studju ta' ħames snin, fejn kemm l-investigatur kif ukoll il-pazjenti kienu jafu x'mediċini kienu qed jintużaw, b'NPH bħala kontrol (NPH jingħata darbtejn kuljum) u fejn il-progress tar-retinopatija bi tlett gradi jew aktar fuq Studju Dwar Trattament Kmieni ta' Retinopatija tad-Dijabete (ETDRS) kien investigat b'ritratt talfundus.
English: This medicinal product contains less than 1 mmol (23 mg) sodium per dose, i.e. it is essentially ‘sodium-free'.
Maltese: Għal kull doża din il-mediċina fiha inqas minn 1 mmol (23 mg) ta' sodium , i.e tista' tgħid li huwa ‘nieqes minn sodium'.
English: The total therapeutic insulin concentration (insulin glargine and its metabolites) found in type 1 diabetic patients was markedly lower than what would be required for a halfmaximal occupation of the IGF-1 receptor and the subsequent activation of the mitogenic-proliferative pathway initiated by the IGF-1 receptor.
Maltese: Il-konċentrazzjoni terapewtika kollha tal-insulina (insulin glargine u l-metaboliti tiegħu) li nstabet f'pazjenti dijabetiċi tat-tip 1 kienet ħafna inqas milli hemm bżonn sabiex tintlaħaq nofs l-okkupazzjoni massima tarriċettur IGF-1 u l-attivazzjoni sussegwenti tas-sensiela ta' reazzjonijiet mitoġeniċi-proliferattivi kkawżati mir-riċettur IGF-1.
English: Plasma “trough” levels of insulin glargine and its main M1 and M2 metabolites were measured in children treated with insulin glargine, revealing plasma concentration patterns similar to adults, and providing no evidence for accumulation of insulin glargine or its metabolites with chronic dosing.
Maltese: Livelli “trough” fil-plasma tal-insulina glargine u l-metaboliti prinċipali tagħha M1 u M2 kienu mkejla fi tfal ikkurati b'insulina glargine, u nstab li l-konċentrazzjoni fil-plażma għandha mudelli simili bħall-adulti, u ġie muri li m'hemm l-ebda evidenza ta' akkumulazzjoni ta' insulina glargine jew il-metaboliti tagħha meta jingħataw dożi regolarment
English: Marketing Authorisation Holder Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Germany.
Maltese: Id-Detentur ta' l-Awtorizzazzjoni għat-tqegħid fis-Suq Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, il-Ġermanja.
English: - The other ingredients are: zinc chloride, metacresol, glycerol, sodium hydroxide (see section 2 “Important information about some of the ingredients of Lantus”) and hydrochloric acid (for pH adjustment), polysorbate 20 (10 ml vial only) and water for injections.
Maltese: Is-sustanzi l-oħra huma: zinc chloride, metacresol, glycerol, sodium hydroxide, (ara sezzjoni 2 “Tagħrif importanti dwar xi wħud mis-sustanzi ta' Lantus”) u hydrochloric acid (għall-aġġustament talpH), polysorbate 20 (kunjett ta' 10 ml biss) u ilma għall-injezzjonijiet.
English: A. Check that the dose window shows “0” following the safety test.
Maltese: Iċċekkja li t-tieqa tad-dożaġġ turi “0” wara li tkun għamilt it-test ta' sigurtà.
English: 5 vials of 5 ml.
Maltese: Kunjett 1 ta' 5 ml.
English: Cartridge
Maltese: Treddigħ
English: Severe allergic reactions (rare, may affect up to 1 in 1,000 people) - the signs may include large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema), shortness of breath, a fall in blood pressure with rapid heart beat and sweating.Severe allergic reactions to insulins may become life-threatening.
Maltese: Reazzjonijiet allerġiċi serji ( rari, jistgħu jaffettwaw sa persuna 1 minn kull 1,000) - is-sinjali jistgħu jinkludu reazzjonijiet tal-ġilda fuq skala kbira (raxx u ħakk mal-ġisem kollu), nefħa severa fil-membrana mukuża (anġioedema), qtugħ ta' nifs, tħarħir, taqa' l-pressjoni fid-demm, polz mgħaġġel jew tkun għarqan.
English: For more information, see the box at the end of this leaflet.
Maltese: Għal aktar informazzjoni, ara l-kaxxa fl-aħħar ta' dan il-fuljett.
English: Each ml of the solution contains 100 units of insulin glargine (equivalent to 3.64 mg).
Maltese: Kull ml ta' soluzzjoni fih 100 unità tas-sustanza attiva insulina glargine (ekwivalenti għal 3.64mg).
English: The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the RMP.
Maltese: AH għandu jwettaq l-attivitajiet u l-interventi meħtieġa ta' farmakoviġilanza ddettaljati fl-RMP maqbul ippreżentat fil-Modulu 1.8.2 tal-Awtorizzazzjoni għat-Tqegħid fis-Suq u kwalunkwe aġġornament sussegwenti maqbul tal-RMP.
English: Rarely, insulin may cause sodium retention and oedema particularly if previously poor metabolic control is improved by intensified insulin therapy.
Maltese: Rarament, l-insulina tista' twassal li jakkumula s-sodju u tiżviluppa l-edema, speċjalment jekk qabel kien hemm kontroll metaboliku fqir li wara tjieb b'terapija intensifikata bl-insulina.
English: Lantus 100 units/ml solution for injection in a vial For further details on handling, see section 6.6.
Maltese: Lantus 100 unità/ml soluzzjoni għall-injezzjoni f'kunjett Għal aktar dettalji fuq l-immaniġġar, ara sezzjoni 6.6.
English: Switch from twice daily NPH insulin to Lantus
Maltese: Insulin gla rgine NPH insulin
English: Each pen contains 3 ml of solution for injection (equivalent to 300 units).
Maltese: Kull pinna fiha 3 ml ta' soluzzjoni għall-injezzjoni (ekwivalenti għal 300 unità).
English: Type 1 colourless glass vial with a flanged cap (aluminium), a stopper (chlorobutyl rubber (type 1)) and a tear-off cap (polypropylene) containing 5 ml of solution.
Maltese: Kunjett tal-ħġieġ tip 1 mingħajr kulur b'għatu bi flanġ ( aluminju), tapp (lastku tal-chlorobutyl (tip 1) ) u għatu li jiċċarrat (polypropylene) li fih 5 ml ta' soluzzjoni.
English: Inject the dose
Maltese: Mediċini użati fid-dijabete.
English: If administration by syringe is necessary, a vial should be used (see section 4.2 and 4.4).
Maltese: Jekk ikun hemm bżonn ta' teħid permezz ta' siringa, għandu jintuża kunjett (ara sezzjonijiet 4.2 u 4.4).
English: Sodium hydroxide (for pH adjustment) Water for injections
Maltese: Sodium hydroxide (għall-aġġustament tal-pH)
English: Medicines that may cause your blood sugar level to rise (hyperglycaemia) include: - corticosteroids (such as "cortisone" used to treat inflammation), - danazol (medicine acting on ovulation), - diazoxide (used to treat high blood pressure), - diuretics (used to treat high blood pressure or excessive fluid retention), - glucagon (pancreas hormone used to treat severe hypoglycaemia), - isoniazid (used to treat tuberculosis), - oestrogens and progestogens (such as in the contraceptive pill used for birth control), - phenothiazine derivatives (used to treat psychiatric disorders), - somatropin (growth hormone), - sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma), - thyroid hormones (used to treat thyroid gland disorders), - atypical antipsychotic medicines (such as clozapine, olanzapine), - protease inhibitors (used to treat HIV).
Maltese: Il-mediċini li jistgħu jgħollu l-livell taz-zokkor f'demmek (ipergliċemija) jinkludu: l-kortikosterojdi (bħal "cortisone", użat għall-kura ta' l-infjammazzjoni) danazol (mediċina li taħdem fuq l-ovulazzjoni), diazoxide (użat għall-kura ta' pressjoni għolja fid-demm), id-dijuretiċi (użati għall-kura ta' pressjoni għolja fid-demm jew iż-żamma eċċessiva ta' fluwidi), glukagon (ormon tal-frixa użat għall-kura ta' ipogliċemija severa), isoniazid (użat għall-kura tat-tuberkulożi), l-estroġeni u l-proġesteni (bħal fil-pillola kontraċettiva, użata għall-kontroll tat-twelid), id-derivattivi ta' phenothiazine (użati għall-kura ta' disturbi psikjatriċi),
English: In general, the side effects in children and adolescents of 18 years of age or less are similar to those seen in adults.
Maltese: Ġeneralment, l-effetti sekondarji fit-tfal u fl-adolexxenti ta' 18-il sena jew inqas huma l-istess bħal dawk li jiġru fl-adulti.
English: Norge sanofi-aventis Norge AS Tlf: +47 67 10 71 00
Maltese: Tlf: +47 67 10 71 00
English: - The other ingredients are: zinc chloride, metacresol, glycerol, sodium hydroxide (see section 2 “Important information about some of the ingredients of Lantus”) and hydrochloric acid (for pH adjustment) and water for injections.
Maltese: - Is-sustanzi l-oħra huma: zinc chloride, metacresol, glycerol, sodium hydroxide (ara sezzjoni 2 “Tagħrif importanti dwar xi wħud mis-sustanzi ta' Lantus”) u hydrochloric acid (għall-aġġustament tal-pH) u ilma għall-injezzjonijiet.
English: HYPERGLYCAEMIA AND HYPOGLYCAEMIA
Maltese: Fil-plażma, is-sustanza ewlenija li tiċċirkola hija l-metabolita
English: Fertility Animal studies do not indicate direct harmful effects with respect to fertility.
Maltese: Studji fl-annimali ma jurux li hemm xi effetti diretti ħżiena fuq il-fertilità.
English: Sanofi Oy
Maltese: Suomi/Finland Sanofi Oy